U.S. Supreme Court rejects J&J appeal over Risperdal drug

[cafead]

via The U.S. Supreme Court rejected a bid by Johnson & Johnson (JNJ.N) to overturn a $70 million jury verdict against the pharmaceutical company for its failure to warn about risks associated with off-label uses of its antipsychotic drug Risperdal.

article source